Annual report [Section 13 and 15(d), not S-K Item 405]

Stock-based Compensation (Tables)

v3.25.3
Stock-based Compensation (Tables)
 12 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Schedule of status of nonvested shares and stock option activity
The following table represents a summary of the status of the Company’s RSAs:
Restricted Stock Awards Shares Weighted-
Average
Grant Date
Fair Value
Outstanding at September 30, 2024 17,500 $ 37.82 
Vested during year 2025 (8,750) 37.82 
Outstanding and expected to vest at 2025 (a) 8,750 $ 37.82 
a.The weighted average remaining contractual term is 0.3 years and the aggregate intrinsic value of RSAs expected to vest is $303.
The following table represents a summary of the Company’s stock option activity:
Number of
Options		 Weighted
Average
Exercise
Price		 Weighted
Average
Remaining
Contractual
Term
(years)		 Aggregate
Intrinsic
Value
Vested and outstanding – September 30, 2024 38,000 $ 33.74  2.3 —
Expired during year 2025 (1,500) —  1.3 —
Vested and outstanding – September 30, 2025 36,500 $ 33.74  1.3 33,580
On December 23, 2024, the Company granted market-based restricted stock units ("MRSUs") to one of its executives, which will be eligible to be earned if at any time prior to September 30, 2027, the average 30-day closing per share price of the Company’s Common Stock exceeds the applicable price per share thresholds set forth below:

Price Per Share Threshold
Number of MRSUs Earned
$35 per share
 5,000
$40 per share
 12,500
$45 per share
 20,500
The assumptions used in the Monte Carlo simulation model to calculate the fair value of the Company’s MRSUs on the grant date are as follows:

Expected volatility of stock price 33.14  %
Risk-free interest rate 4.26  %
Expected term of awards (years) 2.77
Dividend yield 0.76  %
Grant date stock price $ 26.15 
Market-based Restricted Stock Units Shares Weighted-
Average
Grant Date
Fair Value
Outstanding at September 30, 2024 —  $ — 
Granted 38,000 $ 12.32 
Outstanding at September 30, 2025 (a) 38,000 $ 12.32 
a.The weighted average remaining contractual term is 2.3 years and the aggregate intrinsic value of MRSUs expected to vest is $1,317.